KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoco Products (SON) Asset Writedowns and Impairment (2016 - 2025)

Sonoco Products (SON) has disclosed Asset Writedowns and Impairment for 14 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 118.32% year-over-year to $1.1 million, compared with a TTM value of $12.5 million through Dec 2025, down 26.4%, and an annual FY2025 reading of $12.5 million, down 26.4% over the prior year.
  • Asset Writedowns and Impairment was $1.1 million for Q4 2025 at Sonoco Products, down from $5.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $18.6 million in Q2 2023 and bottomed at -$7.6 million in Q4 2021.
  • Average Asset Writedowns and Impairment over 5 years is $3.5 million, with a median of $3.9 million recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 2009.6% in 2024, then skyrocketed 2022.59% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$7.6 million in 2021, then soared by 147.81% to $3.6 million in 2022, then crashed by 91.08% to $323000.0 in 2023, then crashed by 2009.6% to -$6.2 million in 2024, then skyrocketed by 118.32% to $1.1 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SON at $1.1 million in Q4 2025, $5.1 million in Q3 2025, and $1.4 million in Q2 2025.